Feature Channels: Neuro

• share
• favorite_border

In an effort to combat one of the most lethal forms of pediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive Cancer Center are launching a first-of-its-kind clinical trial to evaluate the safety and effectiveness of a cancer vaccine targeting H3 G34-mutant diffuse hemispheric glioma, a highly aggressive brain tumor that is typically found in adolescents and young adults.

• share
• favorite_border

The University of Kentucky’s Sanders-Brown Center on Aging has introduced a groundbreaking initiative, Brain Health Activities, aimed at supporting individuals with dementia and their caregivers.

• share
• favorite_border

At the Vanderbilt University Institute of Imaging Science (VUIIS), scientists are focusing on a previously understudied part of the brain and spinal cord — white matter. Their discoveries could lead to treatments that restore nerve activity through the targeted delivery of electromagnetic stimuli or drugs.

• share
• favorite_border

Dr. Eric Patton from Saint Joseph’s University talks about his new book, Neurodiversity and Work, which looks at ways to make employment better for both companies and neurodiverse employees. He highlights how people with neurodiversity are often very intelligent, focused, innovative and perceptive.

• share
• favorite_border

A new pathway that is used by cancer cells to infiltrate the brain has been discovered by a team of Canadian and American research groups led by the Singh Lab at McMaster University. The research also reveals a new therapy that shows promise in blocking and killing these tumors.

• share
• favorite_border

Researchers at Washington University School of Medicine in St. Louis have developed a way to study aged neurons in the lab without a brain biopsy, allowing them to accurately model the effects of aging in the development of late-onset Alzheimer's disease.

• share
• favorite_border

Menos del 10% de la financiación de la investigación sobre la epilepsia se destina a la salud en los países de menores recursos, a pesar de que el 80% de las personas con epilepsia viven en estos países. La promoción de la investigación mundial sobre la epilepsia y la mejora de las vías de financiación tienen el potencial de aumentar la capacidad de investigación de los países de ingresos bajos y medianos y promover la equidad en la investigación de la epilepsia en todo el mundo.

• share
• favorite_border

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) is excited to announce its tenth annual Forum, taking place from February 27 to March 1, 2025, at the Palm Beach County Convention Center and the Hilton West Palm Beach in Florida.

• share
• favorite_border

Aunque el 80% de las personas con epilepsia viven en países de ingresos bajos y medianos, la mayoría de las investigaciones sobre la epilepsia se originan en regiones de ingresos altos.

• share
• favorite_border

The movement disorder neurology and neurosurgery team at Vanderbilt University Medical Center is set to add focused ultrasound treatment (FUS) as a new tool in the treatment of essential tremor and Parkinson’s disease.

• share
• favorite_border

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Chip F. Howard, Jr., MD, as the 2024 Lifetime Achievement Award winner. This award is the highest honor bestowed by AANEM and recognizes major contributors in neuromuscular (NM) and electrodiagnostic (EDX) medicine.

• share
• favorite_border

The Cedars-Sinai Accelerator program will greet its 10th accelerator class, featuring 10 innovative health-tech startup companies from the United States and around the globe.

• share
• favorite_border

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces John A. Morren, MD, as the 2024 AANEM Advocacy Award winner. The award is presented to Dr. Morren for his significant advocacy efforts in NM and EDX medicine.

• share
• favorite_border

Announcement of contents of the August 2024 issue of Neurosurgical Focus

• share
• favorite_border

The Alzheimer's Association International Conference (AAIC) 2024 is set to take place from July 28th to August 1st at the Pennsylvania Convention Center in Philadelphia, PA. As the premier event for Alzheimer's and dementia research, AAIC brings together scientists, clinicians, and care professionals from around the world to discuss the latest discoveries and innovations in the field.

• share
• favorite_border

Having high blood pressure, specifically high diastolic blood pressure, was linked to a slightly higher odds of ever having migraine in female participants, according to a new study published in the July 31, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. Diastolic pressure is when the heart is resting between beats.

• share
• favorite_border

St. Jude Children’s Research Hospital and Baylor College of Medicine have implicated the neurotransmitter serotonin in ependymoma tumor growth, suggesting a new class of drugs to test against these tumors.

• share
• favorite_border

University Hospitals has received numerous American Heart Association Get With The Guidelines® - Stroke quality achievement awards for ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines, ultimately leading to more lives saved and reduced disability.

• share
• favorite_border

Mayo Clinic scientists are using artificial intelligence (AI) and machine learning to analyze electroencephalogram (EEG) tests more quickly and precisely, enabling neurologists to find early signs of dementia among data that typically go unexamined.

• share
• favorite_border

Historically, seizure action plans have focused on certain high-risk groups of people with epilepsy. But some clinicians say that seizure action plans are important educational and seizure management tools that should be offered to everyone.